Dr. Laramore specializes in treating patients for salivary gland tumors, head and neck cancer, sarcoma of the soft tissue and bone, and genitourinary tumors particularly prostate cancer at UW Medical Center and SCCA Proton Therapy Center.
High tech medicine can be adapted to the individual patient's needs. I enjoy using the latest technological innovations in radiation oncology to design and carry out the optimal treatment for each patient.
Salivary gland tumors; head and neck cancer; sarcoma of soft tissue and bone; prostate cancer; and treatment with fast neutron radiotherapy, proton therapy, and intensity-modulated radiation therapy (IMRT)
- Professor, Radiation Oncology Department, University of Washington School of Medicine
- Radiation Oncologist, University of Washington Medical Center
- Radiation Oncologist, SCCA Proton Therapy Center
- Medical Education: University of Miami School of Medicine, 1976
- Residency: Radiation Oncology Radiation Oncology, University of Washington School of Medicine, 1977-1978
- Fellowship: American Cancer Society Clinical Fellow, 1979-1980
- Pre/Post-doctoral in physics: National Science Foundation, 1965-1970
- Dr. Laramore was recognized as a 2012 and 2016 "Top Doctor" in Seattle magazine's annual survey.
Prior to obtaining a medical degree, George Laramore, MD received a PhD in theoretical physics and was on the faculty of the University of Illinois. He then went to Sandia Laboratories in Albuquerque, New Mexico, where he did theoretical research in surface physics. “In connection with this, I became interested in biological systems and decided to obtain a medical degree,” he said.
Dr. Laramore chose to specialize in oncology “in large part, because I wanted to find a medical specialty that would utilize my training in physics. This led me to Radiation Oncology. I like dealing with cancer patients because they have real problems where a physician can make a difference.”
His research tends to lie on the interface between physics and medicine. “I have been involved with the fast neutron radiotherapy program at the University of Washington almost since its beginning. I have been the principal investigator (PI) of numerous clinical trial protocols involving this modality, and I am currently the PI on a master protocol that allows us to review outcomes of patients treated with neutron radiotherapy and this has produced many papers,” he said.
Dr. Laramore also serves on the Scientific Advisory Board for the Institute for Nano and Molecular Medicine at the University of Missouri and is helping them develop a program in boron neutron capture therapy.
“I have been involved in developing the Seattle Cancer Care Alliance Proton Therapy Center and am the local PI for a Proton Cooperative Group prospective registry trial that well let us track patient outcomes,” he said. He’s also involved with the medical physics group in investigating biological effects associated with the distal Bragg peak of the proton beam.
In his lifetime, Dr. Laramore hopes to see greater individualization of cancer treatment based upon as yet undetermined assays of genes and gene expression.
Outside of work, he enjoys things that keep him physically active, like running, swimming, scuba diving, skiing, hiking, paddle boarding, fly fishing. “I enjoy family activities including foreign travel, too,” he said.